An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Bimekizumab (Bimzelx): CADTH Reimbursement Recommendation: Indication: The treatment of adult patients with active ankylosing spondylitis who have responded inadequately or are intolerant to conventional therapy [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2024 Jun.
Top results in this bookTable of Contents
Spondyloarthritis in over 16s: diagnosis and management.
London: National Institute for Health and Care Excellence (NICE); 2017 Jun. (NICE Guideline, No. 65.)
Upadacitinib (Rinvoq): CADTH Reimbursement Recommendation: Indication: For the treatment of adults with active ankylosing spondylitis who have had an inadequate response to a biologic disease-modifying antirheumatic drug or when use of those therapies is inadvisable. Upadacitinib may be used as monotherapy or in combination with nonsteroidal anti-inflammatory drugs [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2023 May.
Bimekizumab (Bimzelx): CADTH Reimbursement Recommendation: Indication: For the treatment of adult patients with active psoriatic arthritis. Bimekizumab can be used alone or in combination with a conventional non-biologic disease-modifying antirheumatic drug (e.g., methotrexate) [Internet].
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on